|476.02||+5.21||+1.11%||Vol 138.79K||1Y Perf -4.68%|
|Jul 30th, 2021 16:00 DELAYED|
|- -||- -%|
|Target Price||592.50||Analyst Rating||Strong Buy 1.25|
|Potential %||24.47||Finscreener Ranking||★★+ 48.94|
|Insiders Trans % 3/6/12 mo.||-/-/-||Value Ranking||★★+ 48.79|
|Insiders Value % 3/6/12 mo.||-/-/-||Growth Ranking||★★★★+ 64.80|
|Insiders Shares Cnt. % 3/6/12 mo.||-/-/-||Income Ranking||★★+ 42.73|
|Market Cap||7.59B||Earnings Rating||Buy|
|Price Range Ratio 52W %||41.10||Earnings Date||27th Jul 2021|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||4.45|
|EPS Growth Next 5 Years %||7.40|
|Avg. Weekly Volume||124.92K|
|Avg. Monthly Volume||99.94K|
|Avg. Quarterly Volume||90.51K|
Chemed Corp (NYSE: CHE) stock closed at 476.02 per share at the end of the most recent trading day (a 1.11% change compared to the prior day closing price) with a volume of 138.79K shares and market capitalization of 7.59B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 15544 people. Chemed Corp CEO is Kevin J. Mcnamara.
The one-year performance of Chemed Corp stock is -4.68%, while year-to-date (YTD) performance is -10.63%. CHE stock has a five-year performance of 224.11%. Its 52-week range is between 417.41 and 560, which gives CHE stock a 52-week price range ratio of 41.10%
Chemed Corp currently has a PE ratio of 23.90, a price-to-book (PB) ratio of 8.24, a price-to-sale (PS) ratio of 4.80, a price to cashflow ratio of 15.50, a PEG ratio of 2.32, a ROA of 23.36%, a ROC of 32.43% and a ROE of 39.73%. The company’s profit margin is 15.61%, its EBITDA margin is 22.40%, and its revenue ttm is $1.59 Billion , which makes it $99.62 revenue per share.
Of the last four earnings reports from Chemed Corp, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $4.45 for the next earnings report. Chemed Corp’s next earnings report date is -.
The consensus rating of Wall Street analysts for Chemed Corp is Strong Buy (1.25), with a target price of $592.5, which is +24.47% compared to the current price. The earnings rating for Chemed Corp stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Chemed Corp has a dividend yield of 0.28% with a dividend per share of $1.36 and a payout ratio of 6.00%.
Chemed Corp has a Neutral technical analysis rating based on Technical Indicators (ADX : 19.49, ATR14 : 11.75, CCI20 : -20.75, Chaikin Money Flow : 0.05, MACD : -2.25, Money Flow Index : 46.24, ROC : 1.53, RSI : 50.00, STOCH (14,3) : 45.29, STOCH RSI : 0.86, UO : 45.10, Williams %R : -54.71), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Chemed Corp in the last 12-months were:
Copyright © 2016-2021 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
This could take some time, please wait.